HomeCare Guidelines
Care Guidelines
Care Guidelines
Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD
Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare professionals should recognize. Although Duchenne muscular dystrophy (DMD) is primarily known as a genetic neuromuscular condition causing progressive muscle weakness, research has shown that some boys with DMD can also experience differences or delays in...
Care Guidelines
Guide to DMD for Parents and Teachers at School: A Complete Guide for Safety, Learning, Friendship and Inclusion
A well-structured guide to DMD for parents and teachers at school is essential for supporting children with Duchenne Muscular Dystrophy (DMD) in educational environments. DMD is a progressive neuromuscular condition that affects muscle strength, endurance, and sometimes cognitive functioning. These challenges directly influence how a child participates in school...
Keep exploring
Care Guidelines
Bone & Joint Health in Duchenne Muscular Dystrophy: Complete Care Guide
Bone & joint health in Duchenne muscular dystrophy is a critical yet often under-recognized...
Care Guidelines
Fat Embolism Syndrome in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive genetic disorder characterized by muscle degeneration and...
Care Guidelines
Vaccinations in Duchenne Muscular Dystrophy: Essential Protection for Patients and Families
Vaccinations in Duchenne muscular dystrophy (DMD) play a crucial role in protecting patients from...
Care Guidelines
Infection in Duchenne Muscular Dystrophy – Risks, Types, Prevention, and Treatment
Duchenne muscular dystrophy (DMD) is a severe genetic neuromuscular disorder characterized by progressive muscle...
Care Guidelines
Autism Spectrum Disorders in Duchenne Muscular Dystrophy: Genetics, Brain Mechanisms, and Clinical Insights
Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disorder caused by mutations in...
Care Guidelines
Best Respiratory Devices for Duchenne Muscular Dystrophy Patients: Complete Guide to Breathing Support
Respiratory devices for Duchenne muscular dystrophy play a critical role in managing breathing complications...
Care Guidelines
Nutraceuticals for Duchenne Muscular Dystrophy: Supplements That May Reduce Muscle Inflammation
Duchenne Muscular Dystrophy (DMD) is one of the most severe inherited neuromuscular disorders, primarily...
Care Guidelines
Palliative Care in Duchenne Muscular Dystrophy: Complete Guide for Families
Duchenne muscular dystrophy is a progressive genetic condition that affects muscle strength and function...
Care Guidelines
Maintaining for Lung Muscles in Duchenne Muscular Dystrophy: Comprehensive Respiratory Health Care
Duchenne Muscular Dystrophy (DMD) is a progressive genetic disorder characterized by the weakening of...
Care Guidelines
Best Foods and Nutrition Plan for Duchenne Muscular Dystrophy (DMD)
Duchenne muscular dystrophy (DMD) is a progressive genetic neuromuscular disorder characterized by muscle degeneration,...
Care Guidelines
Traveling with Duchenne Muscular Dystrophy: Complete Family Guide
Duchenne Muscular Dystrophy travel requires thoughtful preparation, flexibility, and the right support to ensure...
Care Guidelines
Swallowing Difficulty (Dysphagia) in Duchenne Muscular Dystrophy (DMD): Causes, Impact, and Treatment Options
Swallowing difficulty, medically known as dysphagia, is a common but often under-recognized complication of...
Latest articles
Press Releases
Entrada Therapeutics ENTR-601-45: Early Exon 45 Skipping Study Shows Increased Dystrophin Production
Entrada Therapeutics has announced positive initial results from its Exon 45 Skipping Study, ELEVATE-45-201,...
Press Releases
Entrada Therapeutics Advances ENTR-601-44 to 18 mg/kg in Its Duchenne Exon 44 Skipping Study
Entrada Therapeutics has received clearance to test the highest dose in its Exon 44...
Research
Sapreme Therapeutics Reports Strong Preclinical Dystrophin Restoration With SPM-2551 in Duchenne
Sapreme Therapeutics has announced promising preclinical results for SPM-2551, an experimental treatment for Duchenne...
Press Releases
Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne
Capricor Therapeutics has reported new results from the HOPE-3 study evaluating Deramiocel in people...
Press Releases
Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne
Ractigen Therapeutics has presented positive first-in-human data for RAG-18 (NCT07282652), an investigational treatment for...
Press Releases
Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data
Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for patients with Duchenne muscular dystrophy...
Press Releases
NS Pharma’s Brogidirsen Shows 5-Year Clinical Data in DMD Patients Amenable to Exon 44 Skipping
NS Pharma’s brogidirsen (NS-089/NCNP-02) is an investigational therapy for Duchenne muscular dystrophy (DMD) designed...
Press Releases
ELEVIDYS WMS 2026 Data: What They Show—and What They Don’t
Sarepta Therapeutics has presented new data on ELEVIDYS (delandistrogene moxeparvovec) at the 2026 World...
